Related references
Note: Only part of the references are listed.Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells
M. Khan et al.
ANTIVIRAL RESEARCH (2011)
Ribavirin Potentiates Interferon Action by Augmenting Interferon-Stimulated Gene Induction in Hepatitis C Virus Cell Culture Models
Emmanuel Thomas et al.
HEPATOLOGY (2011)
Ribavirin Enhances Interferon-Stimulated Gene Transcription by Activation of the Interferon-Stimulated Response Element
Qiuwei Pan et al.
HEPATOLOGY (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C
Tommaso Maria Manzia et al.
TRANSPLANT INTERNATIONAL (2011)
Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system
Kyoko Mori et al.
VIRUS RESEARCH (2011)
Mycophenolic Acid Predose Concentrations and Renal Function in a Mouse Model for Progressive Renal Fibrosis
Gunnar Brandhorst et al.
THERAPEUTIC DRUG MONITORING (2010)
The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
Abraham L. Brass et al.
CELL (2009)
Conversion From Calcineurin Inhibitor to Mycophenolate Mofetil-Based Immunosuppression Changes the Frequency and Phenotype of CD4+FOXP3+ Regulatory T Cells
Ahmet Demirkiran et al.
TRANSPLANTATION (2009)
Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-α
Scot D. Henry et al.
GASTROENTEROLOGY (2006)
Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication
Y. Itsui et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction:: Effects on lymphocytes, monocytes, and CD34+ stem cells
Priscilla Yam et al.
MOLECULAR THERAPY (2006)
High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma
CG Patel et al.
THERAPEUTIC DRUG MONITORING (2006)
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
RH Wiesner et al.
LIVER TRANSPLANTATION (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Peginterferon α-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon α-2b plus ribavirin:: A pilot study of efficacy and safety
SK Herrine et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
MMF and calcineurin taper in recurrent hepatitis C after liver transplantation: Impact on histological course
M Bahra et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen et al.
JOURNAL OF VIROLOGY (2005)
Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation
A Kornberg et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2005)
Antiviral action of ribavirin in chronic hepatitis C
JM Pawlotsky et al.
GASTROENTEROLOGY (2004)
Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infection
RJ Firpi et al.
LIVER TRANSPLANTATION (2003)
Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(I)-poly(C), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons
RE Lanford et al.
JOURNAL OF VIROLOGY (2003)
Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C
M Cornberg et al.
JOURNAL OF HEPATOLOGY (2002)
Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
CG Fasola et al.
TRANSPLANTATION PROCEEDINGS (2002)
Identification of active antiviral compounds against a New York isolate of West Nile virus
JD Morrey et al.
ANTIVIRAL RESEARCH (2002)
Hepatitis C and mycophenolate mofetil - A clarification
CG Fasola et al.
LIVER TRANSPLANTATION (2002)
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C
A Jain et al.
LIVER TRANSPLANTATION (2002)
Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs
M Frese et al.
HEPATOLOGY (2002)
Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes
RE Lanford et al.
JOURNAL OF VIROLOGY (2001)
A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients
R Wiesner et al.
LIVER TRANSPLANTATION (2001)
Mycophenolate mofetil and its mechanisms of action
AC Allison et al.
IMMUNOPHARMACOLOGY (2000)